Discovery of hepatitis C virus NS3 helicase inhibitors by a multiplexed, high-throughput helicase activity assay based on graphene oxide

  • Hongje Jang
  • , Soo Ryoon Ryoo
  • , Young Kwan Kim
  • , Soojin Yoon
  • , Henna Kim
  • , Sang Woo Han
  • , Byong Seok Choi
  • , Dong Eun Kim
  • , Dal Hee Min

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

A GO-to solution: A simple graphene oxide (GO)-based assay to screen for selective inhibitors of a hepatitis C virus (HCV) helicase along with inhibitors of a severe acute respiratory syndrome coronavirus (SARS CoV) helicase was tested (see scheme). A single screen found five inhibitors highly selective for the HCV helicase orthologous to the SARS CoV helicase. Some of these hits were validated using the same GO-based assay.

Original languageEnglish
Pages (from-to)2340-2344
Number of pages5
JournalAngewandte Chemie - International Edition
Volume52
Issue number8
DOIs
StatePublished - 18 Feb 2013

Keywords

  • biosensors
  • graphene oxide
  • helicases
  • high-throughput screening
  • multiplex assays

Fingerprint

Dive into the research topics of 'Discovery of hepatitis C virus NS3 helicase inhibitors by a multiplexed, high-throughput helicase activity assay based on graphene oxide'. Together they form a unique fingerprint.

Cite this